NC

Nexthera Capital Portfolio holdings

AUM $120M
This Quarter Return
+12.18%
1 Year Return
+20.18%
3 Year Return
+117.79%
5 Year Return
10 Year Return
AUM
$70.5M
AUM Growth
Cap. Flow
+$70.5M
Cap. Flow %
100%
Top 10 Hldgs %
77.88%
Holding
45
New
45
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 91.72%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PFE icon
1
Pfizer
PFE
$141B
$10.7M 15.11% +330,000 New +$10.7M
BMY icon
2
Bristol-Myers Squibb
BMY
$96B
$10M 14.25% +146,000 New +$10M
CELG
3
DELISTED
Celgene Corp
CELG
$9.58M 13.59% +80,000 New +$9.58M
MRK icon
4
Merck
MRK
$210B
$5.49M 7.79% +104,000 New +$5.49M
SGEN
5
DELISTED
Seagen Inc. Common Stock
SGEN
$4.04M 5.73% +90,000 New +$4.04M
ABBV icon
6
AbbVie
ABBV
$372B
$3.64M 5.17% +61,500 New +$3.64M
CNCE
7
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$3.47M 4.93% +183,000 New +$3.47M
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.12M 4.43% +144,000 New +$3.12M
AGN
9
DELISTED
Allergan plc
AGN
$2.88M 4.08% +9,200 New +$2.88M
ALDR
10
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$1.98M 2.81% +60,000 New +$1.98M
NBIX icon
11
Neurocrine Biosciences
NBIX
$13.8B
$1.53M 2.17% +27,000 New +$1.53M
IOVA icon
12
Iovance Biotherapeutics
IOVA
$807M
$1.18M 1.67% +152,266 New +$1.18M
FPRX
13
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$892K 1.27% +21,500 New +$892K
NDRM
14
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$818K 1.16% +48,000 New +$818K
CTIC
15
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$807K 1.14% +656,000 New +$807K
IMDZ
16
DELISTED
Immune Design Corp.
IMDZ
$803K 1.14% +40,000 New +$803K
AERI
17
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$688K 0.98% +28,240 New +$688K
HRTX icon
18
Heron Therapeutics
HRTX
$207M
$630K 0.89% +23,600 New +$630K
DRRX icon
19
DURECT Corp
DRRX
$59.6M
$622K 0.88% +281,514 New +$622K
SCLN
20
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$598K 0.85% +65,000 New +$598K
QURE icon
21
uniQure
QURE
$896M
$595K 0.84% +36,000 New +$595K
ADXS
22
DELISTED
Advaxis, Inc.
ADXS
$556K 0.79% +55,264 New +$556K
RCKT icon
23
Rocket Pharmaceuticals
RCKT
$354M
$476K 0.68% +42,000 New +$476K
CASC
24
DELISTED
Cascadian Therapeutics, Inc.
CASC
$444K 0.63% +200,000 New +$444K
INO icon
25
Inovio Pharmaceuticals
INO
$126M
$403K 0.57% +60,000 New +$403K